Medicare Enrolled

Dr. Kevin Kempf, MD

Rheumatology · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
19272 STONE OAK PKWY, San Antonio, TX 78258
2102658851
In practice since 2006 (20 years)
NPI: 1003895020 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kempf from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kempf? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kempf

Dr. Kevin Kempf is a rheumatology in San Antonio, TX, with 20 years in practice. Based on federal Medicare data, Dr. Kempf performed 290,070 Medicare services across 8,669 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kempf received a total of $118,964 from 56 pharmaceutical and/or device companies across 1279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kempf is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 1% volume in TX$ $118,964 industry payments

Medicare Practice Summary

Medicare Utilization ↗
290,070
Medicare services
Top 1% in TX for rheumatology
8,669
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~14,504 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Tocilizumab injection (Actemra)84,984$4$17
Certolizumab injection (Cimzia)84,800$4$19
Golimumab infusion (Simponi Aria)39,659$11$48
Abatacept infusion (Orencia)39,600$33$134
Denosumab injection (Prolia/Xgeva)8,040$18$42
Infliximab infusion (Remicade)6,921$25$114
Injection, rituximab, 10 mg4,152$62$257
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg3,350$30$119
Measurement of antibody for assessment of autoimmune disorder, any method2,335$17$44
Comprehensive metabolic blood panel1,496$10$26
Complete blood count (CBC) with differential1,440$8$20
C-reactive protein test (inflammation marker)1,434$5$14
Sed rate test (inflammation marker)1,278$3$6
Office visit, established patient (30-39 min)1,229$89$253
Administration of chemotherapy into vein, 1 hour or less1,193$99$399
Extended-release steroid injection (Zilretta)1,120$13$42
Analysis of substance using immunoassay technique, multiple step method815$11$28
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle564$56$222
Measurement of dna antibody, single stranded438$12$29
Measurement of dna antibody, native or double stranded437$13$35
Vitamin D level test436$29$72
Measurement of antibody for rheumatoid arthritis assessment412$13$32
Rheumatoid factor level410$5$15
Cardiolipin antibody (tissue antibody) measurement375$24$63
Measurement of complement (immune system proteins), antigen,374$12$29
Beta 2 glycoprotein 1 antibody (autoantibody) measurement372$24$63
Administration of chemotherapy into vein, each additional hour273$21$85
Measurement of substance using immunoassay technique243$17$39
Uric acid level test182$4$12
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose172$95$311
Aspiration and/or injection of fluid large joint using ultrasound guidance164$92$300
Creatine kinase (cardiac enzyme) level, total147$6$17
Vitamin B-12 level test126$14$38
New patient office visit (45-59 min)122$122$497
Folic acid level test115$14$37
Thyroid stimulating hormone (TSH) test115$16$42
Injection of additional new drug or substance into vein109$11$47
Injection, methylprednisolone sodium succinate, up to 40 mg87$3$13
Ferritin level test (iron stores)80$13$35
Iron binding capacity test79$8$22
Injection, methylprednisolone acetate, 40 mg79$6$15
Injection, methylprednisolone sodium succinate, up to 125 mg58$4$18
Flu vaccine administration43$30$61
Office visit, established patient (20-29 min)41$65$166
Flu vaccine, quadrivalent39$73$75
Office visit, established patient, complex (40-54 min)38$128$331
Injection, methylprednisolone acetate, 80 mg31$9$28
Injection, methylprednisolone acetate, 20 mg24$3$4
Drug injection, under skin or into muscle22$10$42
Joint injection, major joint17$53$146
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
29.7% high complexity
65.2% medium
5.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$118,964
Total received (2018-2024)
Avg $16,995/year across 7 years
Top 6% in TX for rheumatology
56
Companies
1,279
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$88,541 (74.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,422 (18.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,001 (7.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,744
2023
$3,327
2022
$10,901
2021
$3,065
2020
$10,880
2019
$46,373
2018
$40,674

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$48,585
GlaxoSmithKline, LLC.
$18,188
Amgen Inc.
$13,115
UCB, Inc.
$7,745
Novartis Pharmaceuticals Corporation
$7,534
GENZYME CORPORATION
$5,638
Horizon Therapeutics plc
$4,346
Janssen Biotech, Inc.
$1,481
Lilly USA, LLC
$1,450
Mallinckrodt Hospital Products Inc.
$1,257
E.R. Squibb & Sons, L.L.C.
$1,156
PFIZER INC.
$1,096
Genentech USA, Inc.
$954
Radius Health, Inc.
$670
Regeneron Healthcare Solutions, Inc.
$630
Flexion Therapeutics, Inc.
$579
SANOFI-AVENTIS U.S. LLC
$551
Aurinia Pharma U.S., Inc.
$479
Ferring Pharmaceuticals Inc.
$398
Horizon Pharma plc
$331
AstraZeneca Pharmaceuticals LP
$303
Merck Sharp & Dohme Corporation
$245
Boehringer Ingelheim Pharmaceuticals, Inc.
$241
ANI Pharmaceuticals, Inc.
$206
Pacira Therapeutics, Inc.
$195
Johnson & Johnson Health Care Systems Inc.
$150
Actelion Pharmaceuticals US, Inc.
$149
ABBVIE INC.
$123
AbbVie, Inc.
$112
Hikma Pharmaceuticals USA
$100
Antares Pharma, Inc.
$98
Fresenius Kabi USA, LLC
$96
Mallinckrodt Enterprises LLC
$88
Exeltis, USA Inc.
$86
Teva Pharmaceuticals USA, Inc.
$46
Bayer HealthCare Pharmaceuticals Inc.
$45
Takeda Pharmaceuticals U.S.A., Inc.
$45
Ultragenyx Pharmaceutical Inc.
$44
Organon LLC
$43
Sandoz Inc.
$36
Alexion Pharmaceuticals, Inc.
$33
Mallinckrodt LLC
$31
Nevro Corp.
$31
SCILEX PHARMACEUTICALS INC.
$29
Bioventus LLC
$29
Oxford Immunotec USA Inc
$26
MEDEXUS PHARMA, INC.
$23
Octapharma USA, Inc.
$20
FIDIA PHARMA USA INC.
$17
Ironwood Pharmaceuticals, Inc
$16
Endo Pharmaceuticals Inc.
$13
Kiniksa Pharmaceuticals, Ltd.
$13
SHIELD THERAPEUTICS INC
$13
Cumberland Pharmaceuticals, Inc.
$12
Janssen Scientific Affairs, LLC
$11
MEDAC PHARMA, INC.
$11
Top 3 companies account for 67.2% of total payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AMJEVITA · AREXVY · AVSOLA · Actemra · Adempas · Arcalyst · BELSOMRA · BENLYSTA · BEXSERO · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUZALLO · Durolane · EUFLEXXA · EVENITY · Enbrel · Entyvio · FORTEO · HADLIMA · HYRIMOZ · Humira · Hymovis · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · LUPKYNIS · LYRICA · Mitigare · NASCOBAL · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ONTRUZANT · OPSUMIT · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · Rasuvo · Rituxan · SAPHNELO · SIMLANDI · SIMPONI · SIMPONI ARIA · SKYRIZI · SYNVISC-ONE · Senza · TALTZ · TAVNEOS · TREMFYA · TSPOT TB TEST · Tavneos · Truxima · Tymlos · UPTRAVI · Uloric · Ultomiris · XELJANZ · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for rheumatology in TX.

Equivalent to $41 per 100 Medicare services performed
Looking for a rheumatology in San Antonio?
Compare rheumatologys in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
50
Per 100K population
2.5
County median income
$70,571
Nearest hospital
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kempf is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (speaking/promotional, top 6%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kempf experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Kempf performed 84,984 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kempf receive payments from pharmaceutical companies?
Yes. Dr. Kempf received a total of $118,964 from 56 companies across 1,279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kempf's costs compare to other rheumatologys in San Antonio?
Dr. Kempf's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kempf) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →